Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metreleptin for Hypothalamic Amenorrhea
NCT00130117Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Apr 2010
- Primary completion
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypothalamic amenorrhea (HA) comparing r-metHuLeptin + OCP with Placebo + OCP (2 arms). Primary endpoint: Change in Bone Mineral Content at the Anteroposterior Spine at 36 weeks. Started Apr 2010; status: completed.
02
Drugs
metreleptin
03
Conditions
hypothalamic amenorrhea (HA)
Beyond the preview
Go deeper on NCT00130117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130117.